XRX
48
2
TROW
37
8
CMI
49
2
SJM
17
5
UPS
51
6
AZO
46
3
ED
39
8
LMT
29
-5
DIS
70
2
MAR
57
3
PVH
58
5
HSIC
42
2
UA
48
6
EMC
30
-26
CAG
34
3
NDAQ
46
2
EA
41
3
V
70
14
NEE
39
9
ES
12
3
XRX
48
2
TROW
37
8
CMI
49
2
SJM
17
5
UPS
51
6
AZO
46
3
ED
39
8
LMT
29
-5
DIS
70
2
MAR
57
3
PVH
58
5
HSIC
42
2
UA
48
6
EMC
30
-26
CAG
34
3
NDAQ
46
2
EA
41
3
V
70
14
NEE
39
9
ES
12
3
Financhill
Back

DBV Technologies SA Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison

Sell
31

DBVT
DBV Technologies SA

Last Price:
$3.18
Seasonality Move:
-5.3%
Sell
20

ADAP
Adaptimmune Therapeutics PLC

Last Price:
$0.60
Seasonality Move:
36.97%
Sell
31
DBV Technologies SA (DBVT) is a Sell

Is DBV Technologies SA a Buy, Sell or Hold?

  • The current DBV Technologies SA [DBVT] share price is $3.19. The Score for DBVT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • DBVT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.60. The Score for ADAP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

DBVT Stock Price Chart

What is DBV Technologies SA's stock price today?

  • The DBV Technologies SA share price today is $3.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DBVT is experiencing buying pressure, which is a positive indicator for future bullish movement.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

DBVT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 46.59 Sell
Chaikin Money Flow: 21546 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.68 - 3.78) Sell
Bollinger Bands (100): (3.15 - 4.35) Sell

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 38.3 Sell
Chaikin Money Flow: 3030174 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.6 - 0.7) Sell
Bollinger Bands (100): (0.69 - 1.09) Sell

DBVT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.31 Sell
20-day SMA: 3.39 Sell
50-day SMA: 3.43 Sell
200-day SMA: 4.89 Sell
8-day EMA: 3.27 Sell
20-day EMA: 3.34 Sell
50-day EMA: 3.45 Sell
200-day EMA: 5.18 Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.61 Sell
20-day SMA: 0.65 Sell
50-day SMA: 0.72 Sell
200-day SMA: 1.04 Sell
8-day EMA: 0.61 Sell
20-day EMA: 0.64 Sell
50-day EMA: 0.73 Sell
200-day EMA: 0.93 Sell

DBV Technologies SA Earnings Growth & DBVT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.51 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.85 per share, and a decrease next year of $1.98 per share.

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and a decrease next year of $0.33 per share.

DBV Technologies SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):